Searched by
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | ||||
|
TC-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | ||||
|
TC-0175-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TC-0125-4 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-BV421 |
|
|||
|
virus | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
|
| ATDALMTGY | 4°C | |||||
|
TC-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | ||||
|
TC-0154-2 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | 4°C | |||||
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TS-M115-4 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAKFLHWL | 4°C | |||||
|
TC-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | 4°C | ||||
|
TC-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | ||||
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
TC-0143-2 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-APC |
|
|||
|
virus | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPTLKEYVL | 5-13 | 4°C | ||||
|
TC-0173-1 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | 4°C | ||||
|
TC-0175-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TS-M059-4 |
HLA-A*02:01 AdV 11 Hexon 914-922 Tetramer-LLFEVFDVV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFEVFDVV | 914-922 | 4°C | ||||
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | ||||
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | ||||
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | |||||
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TS-M016-4 |
HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | 4°C | ||||
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | ||||
|
TC-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | ||||
|
TC-0168-4 |
HLA-B*35:01 EBV EBNA1 Tetramer-HPVGEADYFEY-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| HPVGEADYFEY | 4°C | |||||
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | ||||
|
TC-0133-2 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVLDGLLSL | 42-50 | 4°C | ||||
|
TC-0133-4 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVLDGLLSL | 42-50 | 4°C | ||||
|
TC-0154-4 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | 4°C | |||||
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | ||||
|
TC-0162-2 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-APC |
|
|||
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | 4°C | ||||
|
TS-M047-4 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPQLCTEL | 18-26 | 4°C | ||||
|
TS-0008-4C |
HLA-A*02:01 HIV pol Tetramer-ILKEPVHGV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILKEPVHGV | 476-484 | 4°C | ||||
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | ||||
|
TC-0131-1 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TC-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TC-0165-4 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | 4°C | |||||
|
TS-M027-4 |
HLA-A*02:01 HIV gag Tetramer-SLYNTVATL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLYNTVATL | 77-85 | 4°C | ||||
|
TC-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | |||||
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0142-4 |
HLA-B*07:02 HIV gag Tetramer-GPGHKARVL-BV421 |
|
|||
|
virus | BV421 | B*07:02 | 50 tests |
0 (Contact us) |
|
| GPGHKARVL | 223-231 | 4°C | ||||
|
TC-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | ||||
|
TS-M040-4 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | 4°C | ||||
|
TC-0123-2 |
HLA-B*07:02 EBV EBNA 6 Tetramer-QPRAPIRPI-APC |
|
|||
|
virus | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| QPRAPIRPI | 4°C | |||||
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| SLLFLLFSL | 4°C | |||||
|
TC-0121-1 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TC-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TS-M053-4 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLSLGIHL | 575-583 | 4°C | ||||
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TC-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0162-1 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | 4°C | ||||
|
TS-M048-4 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMLDLQPETT | 11-20 | 4°C | ||||
|
TS-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | ||||
|
TC-0107-4 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-BV421 |
|
|||
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | 4°C | |||||
|
TC-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
|||
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | ||||
|
TS-M057-4 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLEETSVML | 316-324 | 4°C | ||||
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | ||||
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | 4°C | ||||
|
TS-M124-4 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RVRAYTYSK | 4°C | |||||
|
TC-0116-2 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | |||||
|
TC-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | ||||
|
TC-0121-4 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TC-0116-4 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | |||||
|
TC-0118-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0121-2 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | |||||
|
TC-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
|
|||
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | 4°C | ||||
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | 4°C | ||||
|
TC-0107-1 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | 4°C | |||||
|
TC-0146-2 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | ||||
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | ||||
|
TS-M043-4 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYDVVSKL | 2594-2602 | 4°C | ||||
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | ||||
|
TC-0173-2 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | 4°C | ||||
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | 4°C | ||||
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| FLWGPRALV | 271-279 | 4°C | ||||
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | ||||
|
TC-0102-2 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-APC |
|
|||
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HLVEALYLV | 4°C | |||||
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | |||||
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | ||||
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | ||||
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | ||||
|
TC-0118-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | ||||
|
TC-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | ||||
|
TS-M122-4 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWALPHAA | 593-601 | 4°C | ||||
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | ||||
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | ||||
|
TC-0165-2 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | 4°C | |||||
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | |||||
|
TC-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | |||||
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | |||||
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | |||||
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||